Alkermes (ALKS) Depreciation & Amortization (CF) (2010 - 2026)

Alkermes (ALKS) reported Depreciation & Amortization (CF) of $19.4 million for Q1 2026, up 161.81% year-over-year from $7.4 million in Q1 2025, and up 405.17% quarter-over-quarter from $3.8 million in Q4 2025.

Alkermes (ALKS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $19.4 million in Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $19.4 million, up 161.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.2 million (up 40.42% YoY), and the FY2025 annual result was $27.2 million, down 4.79% from the prior year.
  • Depreciation & Amortization (CF) improved to $19.4 million in Q1 2026 per ALKS's latest filing, from $3.8 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $19.7 million in Q4 2022 and troughed at $3.8 million in Q4 2025.
  • A 5-year average of $13.4 million and a median of $18.5 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2024 and 2026: Depreciation & Amortization (CF) slumped 64.98% in 2024, then soared 161.81% in 2026.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $19.7 million in 2022, then slipped by 5.77% to $18.5 million in 2023, then sank by 63.07% to $6.8 million in 2024, then slumped by 43.83% to $3.8 million in 2025, then soared by 405.17% to $19.4 million in 2026.
  • Business Quant data shows ALKS's Depreciation & Amortization (CF) at $19.4 million in Q1 2026, $3.8 million in Q4 2025, and $8.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 239.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 19.43 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 22.68 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 21.95 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 497,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 19.43 Mn
Mar 31, 2026 19.43 Mn
Dec 31, 2025 3.85 Mn
Dec 31, 2025 3.85 Mn
Sep 30, 2025 8.08 Mn
Sep 30, 2025 8.08 Mn
Jun 30, 2025 7.82 Mn
Jun 30, 2025 7.82 Mn
Mar 31, 2025 7.42 Mn
Mar 31, 2025 7.42 Mn
Dec 31, 2024 6.85 Mn
Dec 31, 2024 6.85 Mn
Sep 30, 2024 6.97 Mn
Sep 30, 2024 6.97 Mn
Jun 30, 2024 6.66 Mn
Jun 30, 2024 6.66 Mn
Mar 31, 2024 8.06 Mn
Mar 31, 2024 8.06 Mn
Dec 31, 2023 18.54 Mn
Dec 31, 2023 18.54 Mn